Sakariassen Kjell S
KellSa s.a.s., Str., Campo e Zampe 12, I-13900 Biella, BI, Italy.
Future Cardiol. 2007 Jan;3(1):71-90. doi: 10.2217/14796678.3.1.71.
This review focuses on studies of blood flow devices employed in man to unravel the mechanisms of bleeding and thrombotic disorders, and on the characterization of novel experimental antithrombotic entities and drug candidates in biopharmaceutical research and development. Clinical studies with drug candidates and new therapeutic strategies have also been performed, and the predictability of these experimental approaches to clinical situations is excellent. Based on the solid validation of these flow devices, miniature flow devices employing nonanticoagulated blood drawn directly from an antecubital vein should be developed for diagnostic purposes. It is anticipated that such a diagnostic flow device could develop into a personalized medicine approach.
本综述聚焦于人类使用的血流装置研究,以揭示出血和血栓形成疾病的机制,以及生物制药研发中新型实验性抗血栓实体和候选药物的特性。还开展了候选药物和新治疗策略的临床研究,这些实验方法对临床情况的预测性极佳。基于这些血流装置的可靠验证,应开发用于诊断目的的微型血流装置,该装置采用直接从前臂静脉抽取的未抗凝血液。预计这种诊断性血流装置可发展成为一种个性化医疗方法。